Abecma is an approved CAR T-cell therapy for cancer.

Abecma

Breyanzi is an approved CAR T-cell therapy for cancer.

Breyanzi

Kymriah is an approved CAR T-cell therapy for cancer.

Kymriah

Provenge is an approved cellular immunotherapy for prostate cancer.

Provenge

Tecartus is an approved CAR T-cell therapy for mantle cell lymphoma.

Tecartus

Yescarta is an approved CAR T-cell therapy for cancer.

Yescarta

ElionTx is a biotechnology company focused on the development of novel treatments for cancer and other diseases through the use of its proprietary lentiviral vector (LV) platform technology. The company aims to engineer lymphocytes, a type of white blood cell, to target and destroy cancer cells.

ElionTx

industry_trends_dossier

news_impact_assignment_basic

key_people

company_dossier

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

network

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

events

strategic_challenges

network_mapping

industry_trends

transactions_dossier

strategic_challenges_dossier

financial_statements

network_onboarding

company_summary

signals

regulatory_analysis

industry_analysis

swot_dossier

competition_analysis

financial_legal_advisories

merger_acquisitions

swot_analysis

financial_analysis

news_advanced

purchaser_profile

news_impact_assignment_advanced

news_processing_advanced

peers

news_basic

valuation

customer_profile

industry trends dossier	dataroom
company dossier	dataroom
network	dataroom
network mapping	dataroom
transactions dossier	dataroom
network onboarding	dataroom
news impact assignment basic	general
public peers	general	Jun 20, 2024 11:32 AM	f4828fd7
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Jun 20, 2024 12:58 PM	7179d304
company summary	general
signals	general
news advanced	general
news impact assignment advanced	general
news processing advanced	general
peers	general
news basic	general	Jun 20, 2024 11:32 AM	fe7b0733
events	markdown
bundesanzeiger	filings
financial statements	filings
regulatory analysis	company_analysis
industry analysis	company_analysis
competition analysis	company_analysis
financial legal advisories	company_analysis
merger acquisitions	company_analysis
swot analysis	company_analysis
financial analysis	company_analysis
purchaser profile	merger_acquisitions
customer profile	customers

ELIO

COM:ELIONTX

ElionTx